Cohlmia Marketing Published on Oct 25, 2018 – Patient education video on the hospital’s new Robotic-Arm Assisted Technology for partial knee replacements.
Uploaded on Feb 7, 2014
Starting in January 2019, Rio will focus on partial and full knee replacements with the potential to expand to total hip arthroplasty….
…“The real benefit is the accuracy of this machine. Now we can plan the entire surgery before we make a cut,” says Dr. Andili. “It allows us to take a step back and think of different ways to approach the surgery…
16 November 2018
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, presented a number of compelling clinical outcomes around its flagship JOURNEY II BCS knee earlier this month at the American Association of Hip and Knee Surgeons (AAHKS). The announcement follows more than a dozen publications during the past year from various authors around the globe.1-14
In one of the largest multi-center retrospective patient cohorts ever studied, new clinical evidence represented excellent mid-term survivorship results on 2,059 patients with JOURNEY II BCS implants including:
- About 1% of patients required major revision out to 6 years.15
- No major or minor revision of any patient four years or more post-op.15
- Five year revision rate that was reported as 3.6% compared to 4.1% for the cemented posterior stabilized (PS) class in the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR).15
- Statistically significantly better survivorship for patients under 55 when compared to the Australian registry class average for the same age group at 6 years.
Cementless fixation design failures led to low use of this alternative technology. A cementless total knee arthroplasty addressed these design flaws…
…This cementless total knee arthroplasty revealed excellent clinical results at 3-year follow-up and resulted in shortened operative times. Biologic fixation was achieved in 100% of patients with improved functional and objective scores. Early results are encouraging, and this cementless total knee arthroplasty appears to provide an excellent alternative to cemented total knee arthroplasty.
Patients who underwent outpatient TKA had a slightly higher incidence of postoperative deep vein thrombosis, however results showed no differences in terms of cardiac and cerebrovascular events, acute renal failure and pulmonary events between the two groups, he said…
…While [outpatient TKA is] effective in places that have good experience and established protocols, these small differences may reflect trends from centers that have less experience with it, places where they do not do outpatient total joint [replacement] as frequently or do not have as streamlined or well-designed follow-up processes or rehabilitation protocols.
There is an ongoing worldwide temporal decline in mortality following total knee arthroplasty. Improved patient selection and perioperative care and a healthy-population effect may account for this observation. Efforts to further reduce mortality should be targeted primarily at reducing cardiovascular events following total knee arthroplasty.